Dr Reddy's, Hetero to sell generic HIV prevention drug for $40 a year
Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is a twice-yearly injection that was nearly 100% effective at preventing HIV in large trials.

What's Your Reaction?






